Please note that more presentations will be added as we receive them. This list may not include all presentations and that speakers may update their presentations onsite at the conference.

Updates in Metastatic Breast Cancer treatment
Ajit K Bisen, MD, MBA
Dept of General Oncology
Dept of Breast Medical Oncology
UT MD Anderson Cancer Center

Building Meaningful Diversity, Equity, and Inclusivity into Oncology Practice
Dr. Richard Lewis Martin III, MD, MPH (he/him/his)
Medical Director, Health Equity and Community Engagement
Tennessee Oncology
President: ACCC - Tennessee Oncology Practice Society (TOPS)

Genetic Companion Testing in Oncology The Importance of Genetic Counseling and Testing For Hereditary Cancer Syndromes
Gayle Patel, MS, CGC
Texas Oncology

Updates in Gastrointestinal Malignancies
Laith Abushahin MBBS
Texas Oncology
Baylor Charles A Sammons Cancer Center
Dallas, Texas

Managing CAR T Cell Toxicity: Strategies and Insights
Sai Ravi Pingali MD
Associate Professor of Clinical Medicine
Houston Methodist Hospital

Assessing the prevalence and current trends in the use of cannabidiol (CBD) products in patient with active malignancy
Krishna Suthar, MD
Division of Hematology & Medical Oncology, Department of Internal Medicine Baylor Scott and White - Temple
Jess Hatfield, BS
Texas A&M School of Medicine
Patricia Meyer, PharmD
Texas A&M School of Medicine
Lucas Wong, MD
Division of Hematology & Medical Oncology, Department of Internal Medicine Baylor Scott and White - Temple

PRECISION MEDICINE in COMMUNITY ONCOLOGY: A BLUEPRINT
Chris Prakash, MD
Director Quality Services
Lori Brisbin
VP Precision Medicine
TEXAS ONCOLOGY

Federal & State Policy Updates

Systemic Immune Parameters after Prior Radiation Therapy in Patients Receiving Immune Checkpoint Inhibitors
Vatsala Mundra, Yuqiu Ynag, Mitchell S. von Itzstein, Farjana Fattah, Amrit Gonuganta, Raquibul Hannan, Laurentiu Pop, Yuanyuan Zhang, Yiqing Wang, Thomas Sheffield, Yang Xie, Jonathon Dowell, Jade Homsi, Sawsan Rashdan, Jason Park, Quan-Zhen Li, Edward Wakeland, David Gerber

Optimal Timing Between Total Neoadjuvant Therapy and Surgery for Patients with Rectal Adenocarcinoma
Megan Mai, MPH
School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas
Jodi Goldman
School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas
Duke Appiah, PhD, MPH
Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, Texas
Zheng Shi, MD, PhD
Department of Internal Medicine, Texas Tech University Health Sciences Center, Radiation Oncology Clinic, UMC Cancer Center, Lubbock, Texas

Navigating Workforce Challenges in Healthcare
Ray Page, DO, PhD, FACOI, FASCO
The Centers for Blood and Cancer Disorders
Colleen Gallagher, PhD, MS, LSW, FACHE, HECC
UT MD Anderson Cancer Center
Fay J. Hlubocky, PhD, MA, CCTP, FASC, FASCO
University of Chicago Medicine
Todd Pickard, MMSc, PA-C, DFAAPA, FASCO
UT MD Anderson Cancer Center

Exploring Minimally Invasive Interventional Strategies in Hepatocellular Carcinoma Patients: A Comparative Study
Anuttham Kandhadai, BS
Dr. Michael Kueht, MD
The University of Texas Medical Branch, Galveston, TX

Texas Oncology Precision Medicine Program

Additional Resources to Supplement Your Learning

• Cancer Types
  Education and resources to help multidisciplinary cancer care teams stay abreast of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.

On-Demand Webinars

• Achieving Health Equity in the Psychosocial Treatment of Cancer Pain
  Health equity and social justice are critical drivers of quality cancer care, and practice-based solutions are needed to reduce barriers and improve health outcomes. 
• In Pursuit of Equity: Diversity in Clinical Research Participation
  Join Nadine J. Barrett as she details strategies to improve clinical trial accrual for racial and ethnic minorities, as well as other at-risk groups.
  

Podcasts

• Precision Medicine Disparities
  Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC, including increased guideline familiarity, practical applications of guideline-concordant testing, enhancing patient-clinician discussions and education, and access to appropriate clinical trials.

Publications

• Multidisciplinary Chronic Lymphocytic Leukemia Care: Quality Improvement Case Studies
• Metastatic Breast Cancer: Effective Principles in Action
• How White Bagging Impacts Patient Care

   

Articles and Blogs

• The Changing Landscape of Breast Cancer Care
• The Future of White Bagging and Brown Bagging in Oncology Pharmacy 

Digital Tools

• Health Literacy Gap Assessment 
  Help cancer programs identify educational needs and pinpoint areas where targeted education could improve patient care.
• Ask Me 3® Video
  Teaches cancer team members how to better anticipate and respond to patients’ concerns by using a clear, empathetic, and effective approach to communication throughout the care continuum.